Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Pharmacology/Therapy

Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer

New England Journal of Medicine | Feb 25, 2019 Pharmacology/Therapy

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): Disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Oncology | Feb 25, 2019 Pharmacology/Therapy

The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: Revisiting the results of the EORTC-STBSG 62931 randomised trial

European Journal of Cancer | Feb 25, 2019 Pharmacology/Therapy

Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: The MOMA trial

European Journal of Cancer | Feb 25, 2019 Pharmacology/Therapy

Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—A randomised multicentre trial (ASTER trial). An ANOCEF study

European Journal of Cancer | Feb 25, 2019 Pharmacology/Therapy

Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer

Lung Cancer | Feb 25, 2019 Pharmacology/Therapy

Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity

Journal of the American College of Cardiology | Feb 23, 2019 Pharmacology/Therapy

Effect of beta-blocker therapy on early mortality after emergency colonic cancer surgery

British Journal of Surgery | Feb 22, 2019 Pharmacology/Therapy

Safety and efficacy of durvalumab with or without tremelimumab in patients with PD-L1–low/negative recurrent or metastatic HNSCC: The phase 2 CONDOR randomized clinical trial

JAMA | Feb 21, 2019 Pharmacology/Therapy

Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with nivolumab therapy: Three-year follow-up of a randomized phase 3 trial

JAMA | Feb 21, 2019 Pharmacology/Therapy

« Prev 1 … 233 234 235 236 237 … 375 Next »

Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): Disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: Revisiting the results of the EORTC-STBSG 62931 randomised trial

Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: The MOMA trial

Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—A randomised multicentre trial (ASTER trial). An ANOCEF study

Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer

Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity

Effect of beta-blocker therapy on early mortality after emergency colonic cancer surgery

Safety and efficacy of durvalumab with or without tremelimumab in patients with PD-L1–low/negative recurrent or metastatic HNSCC: The phase 2 CONDOR randomized clinical trial

Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with nivolumab therapy: Three-year follow-up of a randomized phase 3 trial

Article: Dietary Approaches for Managing Inflammatory Conditions

Article on Enhancing Anaesthesiology Workflow through Electronic Medical Records: A Case Study

MD Clip on The Glymphatic System in Critical Illness: Unveiling the Brain's Waste Clearance Pathway by Dr Nidhal

Article: Managing Menopause: Hormone Therapy Myths, Benefits, and Risks

Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): Disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: Revisiting the results of the EORTC-STBSG 62931 randomised trial

Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: The MOMA trial

Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—A randomised multicentre trial (ASTER trial). An ANOCEF study

Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer

Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity

Effect of beta-blocker therapy on early mortality after emergency colonic cancer surgery

Safety and efficacy of durvalumab with or without tremelimumab in patients with PD-L1–low/negative recurrent or metastatic HNSCC: The phase 2 CONDOR randomized clinical trial

Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with nivolumab therapy: Three-year follow-up of a randomized phase 3 trial

Article: Dietary Approaches for Managing Inflammatory Conditions

Article on Enhancing Anaesthesiology Workflow through Electronic Medical Records: A Case Study

MD Clip on The Glymphatic System in Critical Illness: Unveiling the Brain's Waste Clearance Pathway by Dr Nidhal

Article: Managing Menopause: Hormone Therapy Myths, Benefits, and Risks

Select Specialty

Select Topic